Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD

NCT04932980 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG: Aflibercept
DRUG: Brolucizumab
PROCEDURE: early treat and extend (T&E)

Sponsor

Berner Augenklinik

Collaborators

medignition AG